In vivo models for numerous diseases and conditions have endpoints that have involved animals being gravely ill or dying. As researchers have sought to utilize animal models in more humane and practical ways, surrogate endpoints have been developed that prevent animals from suffering and provide critical research data.
Using Flow Cytometry as an In Vivo Study Endpoint
Jan 5, 2023 12:54:00 PM / by Champions Oncology posted in Preclinical Flow Cytometry